As of 2024-12-15, the Intrinsic Value of Portage Biotech Inc (PRTG) is
-338.46 USD. This PRTG valuation is based on the model Peter Lynch Fair Value.
With the current market price of 3.00 USD, the upside of Portage Biotech Inc is
-11,381.90%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-338.46 USD
Intrinsic Value
PRTG Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-338.46 - -338.46 |
-338.46 |
-11,381.90% |
| DDM - Stable |
(555.38) - (2,075.97) |
(1,315.68) |
-43955.9% |
| DDM - Multi |
(520.60) - (1,567.99) |
(788.26) |
-26375.2% |
PRTG Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
3.15 |
| Beta |
2.88 |
| Outstanding shares (mil) |
1.05 |
| Enterprise Value (mil) |
-0.15 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.73% |
| Cost of Debt |
5.00% |
| WACC |
9.65% |